Current Affairs Quiz , 17 Jul 2020

1) Chattogram Port, often seen in news, is located in

a) Sri Lanka
b) India
c) Bangladesh
d) None of the above

Answer: c
• Union minister of state for shipping (I/C) Mansukh Mandaviya on Thursday flagged off the first trial container ship from Kolkata to Agartala. … The ship has been launched under the Agreement on the use of Chattogram and Mongla Ports for the movement of India’s transit cargo through Bangladesh

2) NISHTHA programme, recently heard in news, deals with

a) Teacher Training
b) Skill Training
c) Online classes for students
d) None of the above

Answer: a
• Union HRD Minister launched the first on-line NISHTHA programme for 1,200 Key Resources Persons of Andhra Pradesh.

3) Which among the following is not one of the Principal organs of the United Nations?

a) Economic and Social Council
b) UNESCO
c) International Court of Justice
d) None of the above

Answer: b
• The main organs of the UN are the General Assembly, the Security Council, the Economic and Social Council, the Trusteeship Council, the International Court of Justice, and the UN Secretariat. All were established in 1945 when the UN was founded.
• Prime Minister to address High-Level Segment of ECOSOC.

4) Which state in India recently decided to give preference to plasma donors in government jobs?

a) Assam
b) Kerala
c) Tamil Nadu
d) Maharashtra

Answer: a
• The Assam government has decided to go full throttle in pushing blood plasma donation by introducing moves like “state-guest facility” to encourage donors from other states and “letter of recommendation” to encourage donors within the state to battle coronavirus.

5) National Biopharma Mission (NBM) is implemented by

a) Bharat Immunological & Biological Corporation
b) Biotechnology Industry Research Assistance Council (BIRAC)
c) Indian Vaccine Corporation Ltd (IVCOL)
d) Institute of Bio-resources and Sustainable Development

Answer: b
• It is being implemented by the Biotechnology Industry Research Assistance Council (BIRAC).
• BIRAC has announced that ZyCoV-D, the plasmid DNA vaccine designed and developed by Zydus and partially funded by the Department of Biotechnology (DBT) has initiated Phase I/Phase II clinical trials in healthy subjects, making it the first indigenously developed vaccine for COVID-19 to be administered in humans in India.